Fever (drug‑induced) - Symptoms, Causes, Treatment & Prevention

Overview

Drug‑induced fever (DIF) is a rise in body temperature that occurs as an adverse reaction to a medication rather than as a response to infection. The fever typically exceeds 38 °C (100.4 °F) and appears after exposure to the offending drug, often within hours to weeks. While anyone taking medication can develop DIF, certain populations—such as the elderly, patients with multiple comorbidities, and those on polypharmacy regimens—are at higher risk.

Fever is a common adverse drug event. In the United States, adverse drug reactions (ADRs) account for an estimated 2–5 % of all hospital admissions, and drug‑induced fever represents roughly 5–15 % of those ADR‑related admissions (Kim et al., 2020). Worldwide, similar patterns are seen, especially in settings where broad‑spectrum antibiotics, antipsychotics, and immunomodulators are frequently prescribed.

Symptoms

Unlike infectious fevers, drug‑induced fever may be accompanied by a constellation of systemic signs that help differentiate it from other causes.

Core symptom

• Elevated body temperature: Typically 38–41 °C (100.4–105.8 °F). The fever may be continuous, remittent, or intermittent.

Associated systemic symptoms

• Chills or rigors: Often present when the fever spikes.
• Headache: Ranges from mild tension‑type to severe.
• Myalgia and arthralgia: Muscle and joint aches are common, especially with antibiotics and antiepileptics.
• Generalized fatigue or malaise.
• Rash or erythema: May appear with hypersensitivity reactions (e.g., drug reaction with eosinophilia and systemic symptoms – DRESS).
• Urticaria or pruritus: Often concurrent with a cutaneous drug reaction.
• Hepatomegaly or elevated liver enzymes: Seen with hepatotoxic drugs (e.g., certain antitubercular agents).
• Leukocytosis or eosinophilia: Laboratory clues that point toward a drug reaction.
• Hypotension or tachycardia: May occur if the fever is part of a systemic inflammatory response.

Causes and Risk Factors

Common offending drug classes

• Antibiotics: Penicillins, cephalosporins, sulfonamides, and fluoroquinolones.
• Anticonvulsants: Phenytoin, carbamazepine, lamotrigine.
• Antipsychotics & antidepressants: Clozapine, chlorpromazine, selective serotonin reuptake inhibitors (SSRIs).
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): Ibuprofen, naproxen.
• Immunomodulators & biologics: TNF‑α inhibitors, interferons.
• Allopurinol: Often implicated in DRESS.
• Vaccines: Rarely, an immune response to vaccine components may provoke fever.

Mechanisms

• Hypersensitivity reactions (Type I–IV): Immune‑mediated release of cytokines.
• Direct pyrogenic effect: Some drugs act on hypothalamic thermoregulatory centers.
• Metabolic disturbances: E.g., thyroid hormone excess from liothyronine.
• Idiosyncratic reactions: Unpredictable, often linked to genetic susceptibility.

Risk factors

• Advanced age (≥65 years) – reduced drug clearance.
• Renal or hepatic impairment – accumulation of parent drug or metabolites.
• Polypharmacy – increased chance of drug‑drug interactions.
• Previous drug allergy or hypersensitivity.
• Underlying autoimmune disorders.
• Genetic polymorphisms (e.g., HLA‑B*57:01 with abacavir).

Diagnosis

Diagnosing drug‑induced fever is largely a process of exclusion and careful temporal correlation.

Clinical assessment

• Detailed medication history: start dates, dosages, recent changes, over‑the‑counter (OTC) and complementary products.
• Chronology: fever typically appears 1 day to 4 weeks after drug initiation.
• Physical exam: look for rash, lymphadenopathy, organomegaly.

Laboratory tests

• Complete blood count (CBC): May reveal leukocytosis, eosinophilia, or atypical lymphocytes.
• Comprehensive metabolic panel: Assess liver and renal function.
• C‑reactive protein (CRP) & erythrocyte sedimentation rate (ESR): Nonspecific inflammation markers.
• Blood cultures: Performed to rule out infectious causes before attributing fever to a drug.
• Serologic tests: For viral infections (e.g., CMV, EBV) when clinically indicated.
• Drug‑specific tests (rare): Lymphocyte transformation test or drug‑specific IgE when available.

Imaging

• Chest X‑ray or CT scan if pulmonary infection is a concern.
• Ultrasound or MRI when organ-specific involvement is suspected (e.g., hepatic enlargement).

Diagnostic criteria (simplified)

1. Fever ≥38 °C after exposure to a suspect drug.
2. Absence of an alternative infectious, malignant, or autoimmune cause.
3. Improvement of fever within 48–72 hours of drug discontinuation.
4. Re‑challenge (rare, only in controlled settings) reproduces the fever.

Treatment Options

The cornerstone of management is prompt identification and cessation of the offending agent.

Immediate steps

• Stop the suspected drug: If multiple agents are possible, discontinue the most likely culprit first.
• Supportive care: Antipyretics (acetaminophen 650–1000 mg every 6 h) and adequate hydration.

Pharmacologic interventions

• Corticosteroids: Prednisone 0.5–1 mg/kg/day for severe hypersensitivity reactions (e.g., DRESS, Stevens‑Johnson syndrome).
• Antihistamines: Diphenhydramine or cetirizine for urticaria or pruritus.
• Immunomodulators: In rare refractory cases, intravenous immunoglobulin (IVIG) or cyclosporine may be considered.

Alternative medications

If the discontinued drug is essential (e.g., antiepileptic), switch to a structurally unrelated agent with a lower risk of fever. Consult a specialist (infectious disease, psychiatry, neurology) when making substitutions.

Monitoring

• Serial temperature checks every 4–6 hours.
• Daily CBC and metabolic panel for the first 48–72 hours.
• Observe for delayed reactions such as organ involvement.

Living with Fever (drug‑induced)

Daily management tips

• Track medications: Keep an up‑to‑date list (including OTCs, supplements) and share it with every provider.
• Temperature log: Record temperature, time of day, and any associated symptoms.
• Hydration: Aim for 2–3 L of fluid daily (water, oral rehydration solutions) unless contraindicated.
• Nutrition: Small, frequent meals rich in protein and vitamins support immune recovery.
• Rest: Prioritize 7–9 hours of sleep; avoid strenuous activity while fever persists.
• Antipyretic use: Do not exceed recommended acetaminophen dosing (max 4 g/day) to avoid hepatic injury.
• Medical alert ID: Consider wearing a bracelet that lists known drug allergies and the fact that you have experienced drug‑induced fever.

Psychosocial considerations

Repeated drug reactions can cause anxiety about new prescriptions. Engage in shared decision‑making with your health‑care team, and consider consulting a pharmacist for medication‑review services.

Prevention

• Medication reconciliation: At each visit, verify current drug list.
• Allergy testing: When a specific drug allergy is suspected, skin testing or in‑vitro assays may be indicated.
• Start low, go slow: Titrate doses gradually, especially for high‑risk drugs (e.g., antiepileptics).
• Genetic screening: HLA‑B*57:01 testing before abacavir; HLA‑A*31:01 before carbamazepine in certain ethnic groups.
• Avoid unnecessary polypharmacy: Discontinue drugs that are no longer indicated.
• Educate patients: Provide written information about signs of fever and when to call a doctor.

Complications

If drug‑induced fever is not recognized promptly, it can progress to serious sequelae:

• Septic‑like systemic inflammatory response syndrome (SIRS): Fever, tachycardia, hypotension.
• Organ dysfunction: Hepatitis, acute interstitial nephritis, myocarditis.
• DRESS syndrome: Fever, rash, eosinophilia, and multi‑organ failure; mortality 10‑20 %.
• Stevens‑Johnson syndrome / Toxic epidermal necrolysis: Fever precedes severe skin detachment; can be fatal.
• Status epilepticus: In patients on antiepileptics who develop fever, breakthrough seizures may occur.
• Prolonged hospitalization: Increased length of stay and health‑care costs.

When to Seek Emergency Care

Always inform the emergency team about recent medication changes, including dosage and timing.

---

References
Kim, S. et al. (2020). “Incidence and outcomes of drug‑induced fever in hospitalized patients.” JAMA Internal Medicine, 180(9): 1245‑1252.
Mayo Clinic. (2023). “Drug fever.” Retrieved from mayoclinic.org.
CDC. (2022). “Adverse Drug Reactions.” Retrieved from cdc.gov.
World Health Organization. (2021). “Pharmacovigilance and drug safety.” Retrieved from who.int.
Cleveland Clinic. (2022). “Drug‑induced fever.” Retrieved from my.clevelandclinic.org.
NIH. (2021). “Hypersensitivity reactions to drugs.” National Library of Medicine.